Literature DB >> 11006654

Detection of faecal leucocytes & erythrocytes from stools of cholera patients suggesting an evidence of an inflammatory response in cholera.

D R Saha1, S K Niyogi, G B Nair, B Manna, S K Bhattacharya.   

Abstract

BACKGROUND &
OBJECTIVES: Detection of faecal leucocytes and RBCs in stool samples of cholera patients has been reported in a small number of studies. This study extends these observations by examining stool samples of cholera patients in Calcutta.
METHODS: Out of 1562 diarrhoeal stool samples, Vibrio cholerae was isolated in 266 cases. Stool samples obtained were examined microscopically within two hours of collection. RBCs and faecal leucocytes were examined by normal saline and methylene blue stain. Stool culture was performed using selective and differential media for isolation of V. cholerae.
RESULTS: Among 266 cholera patients, RBCs was detected in 58 per cent and faecal leucocytes in 88 per cent respectively. The extent of the changes correlated with clinical severity. INTERPRETATION &
CONCLUSION: This study showed the presence of RBCs and faecal leucocytes in stools of patients of cholera caused by V. cholerae 01 and 0139 which indicates some inflammatory changes in the gut mucosa. Further study is required to elucidate the inflammatory mechanism involved in the underlying process(es).

Entities:  

Mesh:

Year:  2000        PMID: 11006654

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  2 in total

1.  Enterotoxigenicity of mature 45-kilodalton and processed 35-kilodalton forms of hemagglutinin protease purified from a cholera toxin gene-negative Vibrio cholerae non-O1, non-O139 strain.

Authors:  A Ghosh; D R Saha; K M Hoque; M Asakuna; S Yamasaki; H Koley; S S Das; M K Chakrabarti; A Pal
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Transcriptional responses of intestinal epithelial cells to infection with Vibrio cholerae.

Authors:  Neil R Stokes; Xin Zhou; Stephen J Meltzer; James B Kaper
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.